Breast cancer victims 'can double survival time' Trade Arabia Women suffering from breast cancer can survive for twice as long without disease progression using the Novartis-made drug Afinitor (everolimus) in conjunction with hormonal therapy, said a new study. The risk of cancer progression was reduced by 57 per ... |
